Hung Tak Ho serves as Executive at LIXTE BIOTECHNOLOGY HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Hung Tak Ho has executed 1 insider transactions totaling $200.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 30, 2020 involved purchasing 42,105 shares valued at $200.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 30, 2020 | LIXT | $200.0K | Purchase | 42,105 | $4.75 | Discretionary |
Hung Tak Ho currently holds 0 shares of LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hung Tak Ho has been a net buyer of LIXT stock. They have purchased $200.0K and sold $0 worth of shares.
Hung Tak Ho's most recent insider trade was on Nov 30, 2020, when they purchased 42,105 shares at $4.75 per share.
Get notified when new Form 4 filings are submitted